Designer  20261013T135713963

UCITS ETFs arrive on SGX: What investors should know

Equities 4 minutes to read

Key takeaways:

  • More global investment choices on SGX: Four Ireland-domiciled UCITS ETFs list on SGX today, offering exposure to US and global equity markets.
  • Potential tax advantages: Ireland-domiciled UCITS ETFs generally benefit from lower US dividend withholding tax compared with US-domiciled ETFs.
  • Access goes beyond Singapore: Saxo also offers a wide range of UCITS ETFs across international exchanges, giving investors more choice across markets, sectors and asset classes.

What are UCITS ETFs, and why do they matter?

UCITS stands for Undertakings for Collective Investment in Transferable Securities. Despite the complicated name, the concept is simple: these are investment funds that follow a European regulatory framework designed to promote diversification, transparency, liquidity and investor protection.

UCITS ETFs have become popular among international investors because they offer access to global markets through a regulated fund structure. Many are domiciled in Ireland, which can bring additional tax advantages for Singapore-based investors.

For investors, this means that two ETFs tracking the same index, such as the S&P 500, may deliver slightly different net returns simply because of where the funds are domiciled.

Why consider UCITS ETFs?

There are three main potential advantages.

1. Lower dividend withholding tax

For Singapore investors who are not US taxpayers, dividends from US-domiciled ETFs are generally subject to 30% US withholding tax. Ireland-domiciled UCITS ETFs typically face just 15% withholding on dividends received from US companies, thanks to the US-Ireland tax treaty.

For example, if US equities generate a 2% dividend yield, the difference in withholding tax could translate into approximately 0.3 percentage points of additional annual return, before fees and other costs. Over time, even small differences can compound.

2. Potential US estate-tax advantages

Non-US investors holding US-domiciled ETFs may face US estate-tax exposure, particularly when their US-situated assets exceed US$60,000. Ireland-domiciled UCITS ETFs generally avoid direct US estate-tax exposure on those fund holdings.

3. Flexibility to reinvest dividends

Many UCITS ETFs offer accumulating share classes, where dividends are automatically reinvested rather than paid out. This can simplify long-term investing and support compounding without requiring investors to manually reinvest dividend payments.

The important distinction is that these tax advantages relate primarily to Ireland-domiciled ETFs, not every ETF carrying the UCITS label.

What's new? Four UCITS ETFs on SGX

From 13 October 2026, four Xtrackers UCITS ETFs are being cross-listed on the Singapore Exchange, allowing investors to access major global equity benchmarks in Singapore dollars during local trading hours.

ETF

SGX ticker

Exposure

Annual fund fee

Xtrackers S&P 500

XUS

500 leading US companies

0.03%

Xtrackers MSCI World

XWR

Developed-market equities

0.12%

Xtrackers S&P 500 Equal Weight

EUS

US equities with reduced mega-cap concentration

0.15%

Xtrackers Nasdaq 100

XND

Large Nasdaq-listed non-financial companies

0.20%

Source: Xtrackers listing information. Fees shown are published total expense ratios for the existing ETF share classes.

The biggest change is convenience. Investors no longer need to trade on overseas exchanges or convert Singapore dollars into foreign currencies to access these particular funds.

However, trading in Singapore dollars does not eliminate currency risk. Returns still depend on the performance of the underlying investments and their currency exposures.

Looking beyond SGX: A wider UCITS universe with Saxo

While the four new SGX listings are a welcome addition, investors do not need to limit their choices to Singapore-listed ETFs.

Saxo already provides access to a wide range of UCITS ETFs listed across international exchanges, including London and major European markets. These cover US and global equities, emerging markets, government and corporate bonds, technology, healthcare and other investment themes.

For example, investors looking for broad US exposure can explore S&P 500 UCITS ETFs such as CSPX or VUAA, while those seeking global diversification can consider funds such as IWDA or VWRA. Bond UCITS ETFs and accumulating or distributing share classes offer additional flexibility.

With Saxo offering ETF access across more than 30 global exchanges, investors can compare funds based on exposure, costs, liquidity and investment objectives rather than restricting themselves to one exchange.

What are the potential disadvantages?

Despite their benefits, UCITS ETFs are not automatically the best choice for every investor.

  • Liquidity and trading spreads: Newly listed SGX counters may initially see lower trading volumes and wider bid-ask spreads. Some established overseas listings may offer better execution.
  • Foreign exchange exposure: Buying in SGD does not remove the underlying US dollar or other foreign currency exposure.
  • Total costs: Management fees are only one consideration. Brokerage fees, currency conversion charges, trading spreads and tracking differences can affect overall returns.
  • Portfolio overlap: Holding S&P 500, Nasdaq 100 and MSCI World ETFs together may create more concentration in US mega-cap stocks than investors realise.

Investors should also remember that an ETF's listing location does not determine its tax treatment. The fund's domicile and underlying investments matter more.

Bottom line: More choice for Singapore investors

The arrival of UCITS ETFs on SGX is another step towards making global investing more accessible to Singapore investors. The combination of local trading convenience, potential tax efficiency and relatively low fund costs makes these ETFs worth exploring, particularly for long-term portfolios.

But SGX is only one part of a much larger ETF universe. Saxo's broader international offering allows investors to look beyond the new listings and find UCITS ETFs that better match their diversification, income and growth objectives.

The key is not simply choosing between a Singapore-listed or overseas-listed ETF. It is choosing the right exposure, at the right total cost, within a well-diversified portfolio.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.